|
Secondary endpoints
|
8
|
Resverlogix Corp.
|
Oct 11, 2019 02:13PM
|
|
Re: Apabetalone and Alkaline Phosphatase
|
4
|
Resverlogix Corp.
|
Oct 12, 2019 11:00AM
|
|
Re: New Share Price Contest update to Oct 12th
|
5
|
Resverlogix Corp.
|
Oct 13, 2019 05:00PM
|
|
Secondary endpoints
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 06:32PM
|
|
Re: 8 Minutes at AHA
|
10
|
Resverlogix Corp.
|
Oct 25, 2019 02:52PM
|
|
Re: 8 Minutes at AHA
|
3
|
Resverlogix Corp.
|
Oct 25, 2019 04:37PM
|
|
Re: 8 Minutes at AHA
|
2
|
Resverlogix Corp.
|
Oct 25, 2019 05:52PM
|
|
Re: Just back from IR,...
|
5
|
Resverlogix Corp.
|
Oct 26, 2019 05:39AM
|
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 26, 2019 05:51AM
|
|
Re: Just back from IR,...
|
12
|
Resverlogix Corp.
|
Oct 27, 2019 09:47AM
|
|
Re: Just back from IR,...
|
10
|
Resverlogix Corp.
|
Oct 27, 2019 10:24AM
|
|
Re: Just back from IR,...
|
1
|
Resverlogix Corp.
|
Oct 27, 2019 11:28AM
|
|
Re: Is there an obligation....
|
7
|
Resverlogix Corp.
|
Oct 28, 2019 04:57PM
|
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 29, 2019 07:11PM
|
|
Re: Multiple endpoints
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 03:15PM
|
|
Re: A non-rose coloured view of the Webcast
|
3
|
Resverlogix Corp.
|
Nov 02, 2019 01:43PM
|
|
Re: Placebo rate of BETonMACE
|
4
|
Resverlogix Corp.
|
Nov 02, 2019 01:47PM
|
|
Re: A non-rose coloured view of the Webcast
|
2
|
Resverlogix Corp.
|
Nov 02, 2019 02:09PM
|
|
Re: I think one major reason that,
|
5
|
Resverlogix Corp.
|
Nov 02, 2019 02:38PM
|
|
Re: Placebo or Standard of Care
|
3
|
Resverlogix Corp.
|
Nov 03, 2019 07:57AM
|
